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"In this country doctors are,
as a rule, bad citizens, taking
little or no interest in civic, state or national politics. Let me...tell
of one of us ... who ... has found time to serve his city and his country.
For more than twenty years Virchow has sat in the Berlin City
Council as an alderman, and to no feature in his extraordinary life
does the Berliner point with more justifiable pride. It is a
combination of qualities only too rare, when the learned professor
can leave his laboratory and take his share in practical, municipal
work." Wt'lliam Osler,189J'

Colleagues:
The days of summer are fleeting, and September is now upon
us. With that in mind, I wanted to take this opportunity to tell
you about the big plans for the September 11 General Medical
Staff meeting. As I've been telling you for the past few
months, we are planning to demonstrate the PHAMIS 4. N
Patient Management System with computerized order entry.
Representatives from LVH Information Services (1/S) and I will
present a demonstration version of the new system. Over the
past couple of weeks, I've been working with members of the
1/S staff to begin the process of developing our physician order
entry system so that it will be "user friendly" and will help us to
make our hospital rounds more efficient.
In August, the Medical Executive Committee viewed the first
demonstration of the new computerized order entry system,
which is planned for introduction in early summer 2001.
Members of the committee had a number of comments and
suggestions about the demonstration version of the system.
Overall, I felt the first demonstration of this new software
package was a success. However, much needs to be done
before the rollout next year. We all need to be prepared to
help in tailoring the system for our own use.
As well, on September 11, from 7 a.m. to 9 p.m.,
representatives from 1/S will be in the Presidents' Room with
multiple computer terminals set up so that members of the
Medical Staff can sit down and take time to have a "hands on"
demonstration of the system. These terminals will also be
available after the Medical Staff meeting for your use. Please
remember that the demonstration system we will be seeing on
the 11th of September is not the final version that will be
implemented at LVH. The newest version of this software is
being upgraded and will be available in October, 2000.
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Osier, William. Rudolph Virchow: the man and the student. Boston
Med Surg J. 1891; 125:425-7 [Reprinted in McGovern JP, Roland
CG (eds). The Collected Essays of Sir William Osier, vol. III.
Birmingham, AL: Classics of Medicine Library; 1985, pp. 426-7].
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The Physician Order Entry Committee, chaired by Dr. John
Jaffe, will be meeting regularly to help with the rollout of the
computer order entry system so that the members of our staff
will find it workable and easy to use. Members of the LVPHO
Information Services Committee will also help in the
development and rollout of this new and revolutionary system.
From my conversations with Mr. Harry Lukens, Sr. Vice
President and CIO, and members of his 1/S staff, I can assure
you that they want our input and are prepared to do everything
possible to make the introduction of this new system as trouble
free and "physician friendly" as possible. If your input and
recommendations are solicited, please don't hesitate to offer
your opinion. By getting as much participation and buy-in from
the Medical Staff early on, we will be able to have a system
which will work for all of us and will help us do a better job
taking care of our patients.
By now you are probably asking yourself what benefits will I,
as a physician, reap from the use of a computerized physician
order entry system? Below, I have listed just a few.
• Maximizes the efficiency of care
• Reduces delay and errors from transcription
• Permits remote ordering
• Corrects illegible and incorrect orders
• Allows interface of orders to scheduling
• Allows interface of orders with managed care
processes
• Improves quality of care
• Allows direct interface with physicians
• Allows notice of drug interactions
• Provides allergy checking
• Reduces health care costs
• Guides cost efficient choices
• Supports clinical education
• Provides online references
• Provides online rules and references
Once again, I ask for your patience, cooperation, and
assistance as this installation and implementation progresses
over the next nine months. We have much work to do. This
will be "our" system. We can make it work the way we want it
to. I believe in the benefits of this new system. I hope you will
begin to share my enthusiasm for this revolutionary system
that is being implemented primarily to reduce errors and to
improve the quality of care we deliver to our patients.

Page2

Legibility of our medical records continues to be a problem. I'll
remind you again of the action taken at the June Medical
Executive Committee meeting. The committee adopted a
resolution to "require that signatures must be followed ~
the physician's printed name whenever Happears in the
chart. A signature stamp will be provided by the hospital to
physicians who feel that printing their name is too
burdensome." The Medical Record Department will consider
charts, in which signatures are illegible, incomplete, and
appropriate action, as specified in the Medical Staff Bylaws,
will be enforced.
In my last month's Medical Staff Progress Notes article, I
made some remarks about the rising cost of pharmaceuticals
that we prescribe for our patients. I've heard a number of
comments about these remarks. At our Medical Executive
Committee meeting in August, we had a brief discussion about
the topic, and I plan to bring this subject up again for
discussion at the September meeting of the Medical Executive
Committee.
It is not uncommon or unheard of for many of my Medicare
patients with several chronic illnesses to have to spend
upwards of $4,000/year for medications that I have prescribed
for them to deal with their various illnesses. These
medications can be remarkably effective in helping them deal
with their chronic conditions. They may also reduce the
number of hospitalizations that are required to take care of
these patients. With these medications, patients may live
more functional and productive lives. I am all in favor of the
development and marketing of new and effective medications
which are proven in large controlled studies to help reduce
morbidity, prolong life, reduce hospitalization, and improve the
quality of life. I recognize that the development of these new
medications cost a great deal of money for the pharmaceutical
industry, which invests in research and development required
in producing these new products. I also believe that monetary
incentives are necessary to stimulate this research which, on
many occasions, is not rewarded with the success of
marketing a new drug.
I am very concerned, however, with several aspects of the
current pharmaceutical industry's approach to drug
development and marketing. The first of these is the
development of "look alike" drugs. Do we really need 15 to 20
ACE inhibitors for the treatment of hypertension, CHF, and
diabetic renal disease? Do we really need four "proton pump"
inhibitors at $3.00/capsule for the treatment of acid reflux
disease? These are just examples of the tendency for
competing drug companies to develop similar drugs with minor
chemical modifications so that they can reduce their R&D
costs and then devote huge marketing budgets to promote
these medications to physicians and now directly to the public.
(Continued on Page 3)
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All of the drug companies want to get on the "gravy train" so
they can share in the windfall profits that are now available in
this uncontrolled mari<etplace.
Why do most of these "look alike" drugs cost almost the same
amount for a one-month supply? Each company knows that
the mari<-up on their drugs is so high that by competing on
price they would soon be involved in a price war and they
would all lose. With the advent of drug prescription plans that
pay for medications, the pharmaceutical industry is unfettered
in its propensity to continually increase the cost of drugs to our
patients and to those who pay for the drugs. We, the
physicians, are the consumers, but we do not bear any of the
responsibility for having to pay for medications that we
prescribe for our patients. Our patients are placed in the
position of having to pay for medications which they have no
choice in selecting. They can't decide whether they want to
buy the BMW or the Yugo when it comes to prescription
medications. The usual mari<et forces that drive consumer
choices do not apply to prescription drugs that are prescribed
by physicians and taken by patients.
Would you want your physician recommending a drug for your
use because he has been given tickets to the U.S. Senior
Open at Saucon Valley Country Club, the Philadelphia Phillies,
or the Philadelphia Eagles? I don't believe that I should
choose a medication for my patient because I was given $40
worth of Chinese food at Wegman's at a "dine & dash," or free
ice cream at Ice Cream World, or bagels at Chesapeake Bagel
Company on Tuesday and Thursday mornings every month?
Ask yourself, "Why are the majority of the drug representatives
very attractive young women {or handsome young men)?" I
believe that my colleagues and I should be receiving our drug
information from appropriate, reputable, readily available peer
reviewed sources in the medical literature, not from attractive
salespersons who hand out pens, notepads, paperweights,
coffee mugs, and the like. Just imagine what could happen to
the mari<et price of prescription medications if the
pharmaceutical companies reduced their mari<eting budgets by
25- 50%, used this windfall to reinvest in R&D, and lowered
the price of prescription medications. Wouldn't that be a
revolutionary thought! What would happen if we depended on
intelligent physicians to prescribe medications based on their
knowledge about pharmaceuticals obtained from the peer
reviewed medical literature? What might happen if all
members of the LVH Medical Staff read The Medical Letter2
every two weeks?
Remember, we are not talking about antibiotics which are
usually only used for a short time period. I am primarily
concerned about medications that are prescribed for chronic
2

conditions. Fortunately, many of us can afford to purchase
these medications because of our success or good luck. Many
Americans are not as fortunate. Wouldn't it be better for Merck
to sell Zocortm for $0.20/tablet to the 10 million Americans who
would benefit from its use than to sell it for $2.00/tablet to the
one million who were fortunate enough to be able to afford it?
Wouldn't it be great if people could afford to take their
medications and buy groceries at the same time?
I hope that I am not the only physician on this medical staff
who is outraged by the continuing rise in prescription drug
prices. I hope that other members of our staff are equally
concerned by the exorbitant profits that the pharmaceutical
industry reaps at the expense of our patients. Prescription
drug costs rose by approximately 14% last year. It has been
estimated that 18% of the nation's health care budget is
related to physician charges. The same study estimates that
prescription drug costs account for 20% of the nation's health
care budget! I hope that the members of our Medical Staff will
write to their senators and congressmen supporting federal
legislation designed to place some control on prescription drug
costs, and to control the huge expenditures that the drug
companies spend on mari<eting to physicians and directly to
the public. (We should all be cognizant of Osler's comments
about Virchow and the value of physician involvement in a
political cause.)

Many of you remember my involvement in a project several
years ago to try to improve our care for patients with
congestive heart failure. This project included efforts to
shorten inpatient length of stay, reduce the costs of inpatient
care, improve the quality of outpatient care, and reduce the
readmission rate for these patients. Dr. Keith Doram has
been managing this project for over one year. I've recently
received some data about the success of this program. From
July, 1999 through May, 2000, the length of hospital stay for
patients admitted with a diagnosis of CHF has fallen from 5.6
days to 4.5 days. The average cost/case for patients
hospitalized with CHF over the same period fell from $2,100 to
slightly less than $1,800. This is real progress! I want to
commend Dr. Doram and all of those involved in this project for
their successful efforts. A great deal of the credit for this
success is due to the efforts of all of the physicians who care
for patients with congestive heart failure admitted to LVH and
LVH-M.
(Continued on Page 4)
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I look forward to seeing you at the General Medical Staff
meeting on Monday, September 11, at 6 p.m., in the
Auditorium at Lehigh Valley Hospital, Cedar Crest & 1-78. We
will be nominating and holding the election for the new
President-elect of the LVH Medical Staff at this meeting.
Please try to attend this important meeting. Also, please take
some time to stop by the Presidents' Room between 7 a.m. to
9 p.m., on September 11 for a hands-on session with the
physician order entry software!

tl~

David M. Caccese, MD
Medical Staff President

Physician Order Entry Is Coming ...
Demo's with hands-on sessions will be
available for members of the Medical Staff
on Monday, September 11, from 7 a.m. to 9
p.m., in the Presidents' Room at Lehigh
Valley Hospital, Cedar Crest &I-78.
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Interactive Safety Training
According to the Joint Commission on the Accreditation of
Healthcare Organizations (JCAHO), all members of the
hospital's staff, including employees, volunteers, and
physicians, must complete an annual mandatory safety training
program. To accomplish this paramount task in a more
efficient, user-friendly manner, the hospital has introduced a
new computer-based interactive learning system.
This system -- de'Medici -- has been installed on numerous PC
workstations throughout LVHHN and encompasses all
JCAHO/OSHA requirements such as fire safety, infection
control, bloodborne pathogens, workplace violence, and
emergency preparedness.
The following areas are available for physicians to drop in to
do their de' Medici training:

Cedar Crest & 1-78
Learning Resource Center
Health Sciences Library
17fh & Chew
Medical Staff Lounge
Health Sciences Library

LVH-M

Ambulation Protocol Approved
At its June 6 meeting, the Medical Executive Committee
approved an ambulation protocol that was designed to
facilitate early and appropriate ambulation with patients.
Education related to the protocol is currently underway, and
implementation is scheduled for October, 2000.
If you have any questions, please contact Kathleen Baker,
Director of Physical and Occupational Therapy, at (610) 4028480.

Medical Staff Lounge
Health Sciences Library
As you may know, JCAHO inspection of Lehigh Valley Hospital
is scheduled for later this year. Therefore, ALL members of
the staff should complete their training before the end of
October.
If you have any questions regarding the de'Medici interactive
safety training, please contact Suzanne Rice via e-mail or at
484-884-2560.

Medical Staff Dues

Cancer Staging at LVH-Muhlenberg
In order to comply with the Commission on Cancer's program
accreditation requirements, cancer staging is being
implemented at LVH-M on September 1, 2000. Physicians
with privileges at LVH-Muhlenberg will receive an individual
mailing which contains a description of the staging process, a
listing of the organ sites for which staging is required, and

samples of several staging sheets. If you have any questions
regarding this issue, please contact the Tumor Registry at
(610) 402-0520.

On September 1, letters regarding annual Medical
Staff dues will be distributed to members of the
common Medical Staff of Lehigh Valley Hospital and
Lehigh Valley Hospital-Muhlenberg. Payment of dues is
requested on or before September 15, 2000. Timely
remittance of dues is both requested and appreciated.
If you have any questions regarding your Medical Staff
dues, please contact Janet M. Seifert in Physician
Relations at (610) 402-8590.
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News from the HIM Department
Document Imaging
Dictation Record View
Input from physicians has been requested for ways to improve
the document imaging system. One of the concerns is the
increased time it takes to do dictations after records are
scanned into the imaging system. In an effort to improve the
process, "Physician Dictation View" has been created. The
dictation view eliminates all of the administrative documents
from view. To utilize this view, scroll on the tool bar directly
above the document lists until you get to the "Physician
Dictation View" (views are in alphabetical order). Click on the
"Physician Dictation View" and only the documents in this view
will appear. If you need to view documents not contained in
this view, you may, at any time, change to the "All Documents"
view.
Record Completion Process
Wednesday, prior to current week, letters are mailed to
medical staff listing all medical records with deficiencies.
Thursday, prior to current week, resident staff receive letters
for deficiencies.
Monday of current week, a list is generated of all pending
suspension charts, including any H&Ps and OPs which have
not been completed.
Tuesday of current week, a courtesy call is placed to all
physicians who have deficiencies that are listed as "pending
suspension" stating that these must be completed by
Wednesday of the current week.
Wednesday of current week, a suspension list is generated
at 3 p.m. for deficiencies not completed by this time.
Deficiency Assignment
Deficiency assignments are made according to the guidelines
that have been established by physician groups or individual
physicians. The same guidelines that were in place prior to
the document imaging system are being utilized, unless new
instructions were provided to the HIM Department by the
physicians. If changes need to be made to the assignment
process, please contact the HIM Department.
For ease in completing records, the document imaging system
continues to be available on any "document imaging enabled"
workstation on the units or in the HIM Department. The
system enables the HIM Department staff to alert the
physicians to chart deficiencies (histories and physicals) within
24 hours after admission. Once the dictation has been
transcribed, the deficiency is translated into a sign deficiency
automatically. Since the system is updated on an ongoing
basis, it is a good idea to sign in for chart completion
frequently.
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Pending Suspension Deficiencies
Remember, in the old paper world when physicians had to
physically report to the HIM Department, the HIM staff knew
when records were completed. With access conveniently
available throughout the organization, even though the system
is constantly checked, it is sometimes difficult to know that all
suspension deficiencies have been completed. Please notify
the HIM Department if you have completed "pending
suspension" deficiencies outside the HIM Department at (61 0)
402-8345.
Persona/Identification Number
If you forget your "signing PIN number," please call the liS
Help Desk at (610) 402-8303. Staff is available Monday
through Friday, 8 a.m. to 5 p.m. to assist you. Your PIN
number is utilized for electronic signature/chart completion and
does not interfere with your ability to access and review
historical medical records.
If you have any questions regarding Document Imaging,
please contact Sue Cassium, Operations Coordinator, at (610)
402-4451.

Verbal/Telephone Orders
Please remember to check your charts on rounds every day for
yellow "sign-here" labels that indicate that there is a
verbal/telephone order that needs a signature.

For Your Calendar
:Jo>

A meeting of the General Medical Staff will be
held on Monday, September 11, beginning at 6
p.m., in the Auditorium at Lehigh Valley Hospital,
Cedar Crest & I-78. An election of the next
President-elect of the Medical Staff will be held
at the meeting. All members of the Medical
Staff are encouraged to attend.

:Jo>

The quarterly General Membership Meeting of
the Greater Lehigh Valley Independent
Practice Association will be held on Tuesday,
September 26, at 6 p.m., in the Auditorium of
Lehigh Valley Hospital, Cedar Crest & I-78. To
receive credit for your attendance toward the
Incentive Plan, please remember to sign in.

:Jo>

The next Physician Recognition Dinner will be
held on Saturday, March 31, 2001, at the
Holiday Inn Conference Center in fogelsville.
Please mark your calendar! More information will
follow as the date gets closer.
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Patient Transport Service
In an effort to decrease the amount of time that patients wait to
go to testing or return from testing, members of Clinical
Services and Materials Management have worked together to
create a Patient Transport Service which will begin on
September 5 at Cedar Crest & 1-78.
Currently, patients are transported by Support Partners.
Through a study completed by a workflow analysis group, it
was found that Support Partners spend 60% of their time off
the floors transporting patients. This results in decreased
productivity on the units.
With the new Patient Transport Service, transporters will be
dispatched through a centralized location. This should
decrease the amount of patient wait time and allow for
increased productivity by Support Partners on the units.
Hours for the Patient Transport Service will be 7 a.m. to 8 p.m.,
Monday through Friday, and 7:30 a.m. to 4 p.m., on weekends
and holidays. The main telephone number for the Patient
Transport Service is (610) 402-6777.
If you have any questions regarding this service, please
contact Will Mest, Supervisor, Mailroom/Printshop, at (610)
402-5043.

Upcoming Screening Programs
Legs for Life Screening
The early detection and treatment of vascular disease can
mitigate more serious future health problems. Lehigh Valley
Hospital-Muhlenberg will host Legs for Life, a free Peripheral
Vascular Disease (PVD) screening program for the community,
as part of a national screening week sponsored by the Society
of Cardiovascular & lnterventional Radiology (SCVIR). SCVIR
is the national professional society of interventional radiologists
~ho t~at PVD and many other conditions using minimally
1nvas1ve procedures that are often alternatives to surgery.
Lehigh Valley Hospital-Muhlenberg will offer Legs for Life
screenings in the following locations throughout the area:
September 25 • 6 to 9 p.m.
Health Center at Trexlertown
Trexler Mall, Route 222, Trexlertown
September 26 • 8 a.m. to Noon
Lehigh Valley Hospital-Muhlenberg
Outpatient Registration - Kolb Center
2545 Schoenersville Road, Bethlehem
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September 27 • 6 to 9 p.m.
Lehigh Valley Hospital
Diagnostic Care Center- Jaindl Family Pavilion
Cedar Crest & 1-78, Allentown
September 28 & 29 • 10 a.m. to 2 p.m.
Senior Horizons
Agricultural Hall, Allentown Fairgrounds
17th & Chew Streets, Allentown

Pre-registration is requested for the program. Patients may
call (610) 402-CARE to register.
During the screening, participants will answer a brief
questionnaire to assess their risk for PVD. Medical staff will
determine the Ankle Brachial Index (ABI) for signs of
circulatory problems. Participants with multiple risk factors and
symptoms, and those with abnormal ABis, will be advised to
visit their primary care physician. The results from your
patient's participation in the program, along with the screening
physician's recommendations, will be sent to you following the
program completion. If identified, you can then guide your
patients in an appropriate treatment program.

National Depression Screening Day
In observance of National Depression Screening Day on
Thursday, October 5, the Department of Psychiatry will offer
free screenings at the following locations:
Lehigh Valley Hospital
John & Dorothy Morgan Cancer Center
1240 S. Cedar Crest Blvd.
Classrooms 1A & 1B
Allentown, Pa.
3 to 5 p.m.
Lehigh Valley Hospital-Muhlenberg
Banko Family Community Center
2545 Schoenersville Road
Rooms 1 &2
Bethlehem, Pa.
4 to 7 p.m.
Each session will begin promptly with an education lecture and
slide presentation. Free, anonymous depression screenings
will follow.
Reservations are suggested, but not required. For more
information or to make a reservation, please call (610) 402CARE.
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Good Shepherd Specialty HospitalAllentown Highlights its Programs

~

~

Medically stable but fragile patients often need extended
clinical care. Patients needing this level of care may be too ill
for discharge to an acute rehabilitation hospital, nursing facility
or their homes. For such patients, the Good Shepherd
Specialty Hospital-Allentown (GSSH-A) provides outstanding
acute care tailored to the needs of the patient. Over the next
few months, the three major programs --Pulmonary Ventilator,
Complex Medical, and Transitional Rehabilitation --will be
highlighted in Medical Staff Progress Notes.
The Pulmonary Ventilator Program - Under the direction of an
experienced critical care pulmonologist, GSSH-A provides an
aggressive team approach to meeting the needs of the
complex respiratory patient. Patients with tracheostomies,
those on ventilators, and those requiring extensive help to
maintain normal breathing without mechanical support are
ideal candidates for this program.
GSSH-A has 24-hour/day coverage by Registered Respiratory
Therapists. All have at least five years of critical care
experience at leading centers of excellence, including Lehigh
Valley Hosptial and Thomas Jefferson University Hospital.
Therapists are experienced in waveform analysis, drawing
ABG's, use of the lnexsufflator, Intra-pulmonary Ventilator,
BIPAP, and are current with the new respiratory technology to
enhance patient weaning and comfort.
Currently, GSSH-A uses 7200 Ventilators with waveforms,
flowby, pressure support, pressure controlled ventilation
mechanisms and many other functions to enhance weaning.
In addition, transport ventilators are available for patients
requiring mechanical ventilation to facilitate patient mobility
and ease of transport for special studies or procedures as are
walking ventilators for patients that are slow weans but can
benefit from more aggressive physical, occupational and
speech therapy.
Team conferences, led by the attending physician and
including all members of the care team (respiratory, physical,
occupational, speech therapy, care management, pharmacy
and nursing), are held to evaluate individual patient needs and
develop treatment plans to maximize progress toward goals.
On-going patient and family education, that is disease specific,
is part of the individualized treatment plans to maximize
personal independence.
If you have any questions or would like further information
regarding the PulmonaryNentilator Program, please contact a
member of the administrative team listed below or Stephen C.
Matchett, Director, PulmonaryNentilator Program, at (610)
439-8856 or pager (61 0) 920-7225.

~

~
~
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Jane Dorval, MD, President, Medical Staff, (610) 7763340 or pager (610) 830-2793
Beverly Snyder, RN, Assistant Administrator/Director of
Nursing, (610) 402-8599 or pager (610) 830-7665
Joseph Pitingolo, Administrator, (61 0) 402-8559 or pager
(610) 830-4023
Linda Dean, Administrative Consultant, (61 0) 402-8963 or
pager (610) 830-3110
Nancy Hardick, Medical Staff Affairs, (610) 402-8962

Do You Currently Have a Cafeteria Account?
If so, your account number will be changing within
the next few weeks. For those physicians who
currently have cafeteria accounts, barcode
stickers were issued to you when the new
cafeteria barcode system was implemented.
However, in an effort to simplify the process, the
new Photo ID badges have built-in barcodes on
the back of the badge. These barcode numbers
will be input into the cafeteria barcode system
and will replace your existing account number.
Your new barcode number will go into effect on
Friday, September 29.
For those physicians with existing cafeteria
accounts, new ID badges have been ordered and
are available in Medical Staff Services on the
first floor (just up the hall from Medical Records
and the Medical Staff Lounge). If you have not
yet picked up your new ID badge, please stop in
Medical Staff Services, 8 a.m. to 5 p.m., Monday
through Friday. If you have any questions, please
contact Janet M. Seifert in Physician Relations at
(610) 402-8590.

Congratulations!
Jon E. Brndjar, DO, and David M. Stein, DO, Division of
General Internal Medicine, were recently notified of their
election into the Conclave of Fellows of the American College
of Osteopathic Internists. They will be recognized and
awarded their fellowship certificates at the ACOl's annual
convention to be held October 4-8 in Boston, Mass.
Mark A. Gittleman, MD, Division of General Surgery, has
been named an auditor for the Senologic International Society,
which is an international society for the study of breast disease
and breast cancer treatment.
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2000 United Way Campaign
Lehigh Valley Hospital and Health Network will kick off its 2000
United Way Campaign on September 21, 2000. This year,
LVHHN's goal is a gift of $230,000 to the community! Last
year, with the help of hundreds of LVHHN physicians and staff,
nearly $220,000 was raised to support more than 115 health
and human services programs. In order to guarantee the
community easy access to high-quality, diverse programs,
each United Way funded program is reviewed with careful
consideration. With input from its volunteers and donors,
United Way supports programs and initiatives that deliver the
impact and results which the community needs. Their mission
is to increase the organized capacity of people to care for one
another. By helping people when they need it most - in the
formative years of early childhood- we can prevent problems
before they develop and significantly increase the number of
successful adults in our community. That's why three of United
Way's four strategic goals address the needs of children: 1)
Children healthy and ready to learn when they start school; 2)
Children succeeding in school; 3) Young people making
positive choices, and 4) A safety net of services.
This year's LVHHN campaign theme is "A Dollar Round-Up for
OUR Community." This theme builds on the legend of the
Lone Ranger and Tonto. This profound message embedded in
the Lone Ranger Creed echoes our plea for your support.
"I believe that to have a friend, a person must be one. That all
people are created equal and that everyone has within themselves
the power to make this a better world. Our Higher Power put the
firewood there, but that every person must gather and light it
themselves. In being prepared physically, mentally, and morally to
fight when necessary for that which is right."
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At its August 8 meeting, the Medical Executive
Committee reviewed and approved the
Withholding/Withdrawing Treatment Policy. A
copy of the policy is attached for your
information and review.

Papers, Publications and Presentations
Dennis B. Cornfield, MD, Section of Hematopathology, coauthored a paper-- "Follicular Lymphoma Can Be
Distinguished From Benign Follicular Hyperplasia by Flow
Cytometry Using Simultaneous Staining of Cytoplasmic bcl-2
and Cell Surface CD20" -- which was published in the August,
2000 edition of the American Journal of Clinical Pathology.
Gabriela Ghitulescu, MD, former Colon/Rectal Surgery
resident, co-authored a chapter with lndru T. Khubchandani,
MD, Division of Colon and Rectal Surgery, titled, "The
Genetics of Colon and Rectal Cancer," which was included in a
book published by Revinter Brazil in July 2000 -- New Trends
in Coloproctology. This was a multi-author book with invited
contribution by authors from around the world.
Mark A. Gittleman, MD, Division of General Surgery,
presented a Stereotactic Breast Biopsy Seminar at Gottlieb
Memorial Hospital in Melrose Park, Ill., on July 8.
Herbert C. Hoover, Jr., MD, Chairperson, Department of
Surgery, co-authored the article, "Somatostatinoma of the
ampulla of Vater in celiac sprue," which appeared in the
July/August, 2000 issue of the Journal of Gastrointestinal
Surgery.

Please fight for that which is right by supporting this year's
campaign!

All physicians and staff will be receiving a personalized pledge
and designation form in the upcoming weeks. Please join
Elliot J. Sussman, MD, David M. Caccese, MD, Robert J.
Laskowski, MD, Mark C. Lester, MD, Brian A. Nester, DO,
Donald L. Levick, MD, Theresa A. Ryan-Mitlyng, MD, John
Jaffe, MD, Louis L. Liebhaber, and other organizational leaders
through a pledge to this year's campaign. For more
information, please refer to the United Way Intranet website on
the LVHHN Intranet or contact a member of the campaign
team: Linda Durishin (484-884-4867), Maureen Sawyer (484884-2304) or Donna Kulp (484-884-4860).
The United Way is the way to a better Lehigh Valley!

lndru T. Khubchandani, MD, Division of Colon and Rectal
Surgery, was the Program Chairman at the XVIII Biennial
Meeting of the International Society of University Colon and
Rectal Surgeons held in Sao Paulo, Brazil, from July 23 to 27.
Dr. Khubchandani serves as Director General of this society.
Dr. Khubchandani participated in the Panel on Carcinoma of
the Rectum and gave an oration titled, "New Trends in the
Management of Inflammatory Bowel Disease," at the Conjoint
Meeting of the Brazilian Society of Colon and Rectal Surgeons.
Gary G. Nicholas, MD, Program Director, General Surgery
Residency; Dona C. Hobart, MD, former General Surgery
resident; James F. Reed Ill, Senior Scientist/Biostatistician,
Department of Community Health and Health Studies; and
Susan Nastasee, former surgical editor, co-authored the
paper, "Carotid endarterectomy outcomes research: reduced
resource utilization using a clinical protocol," which appeared
in the August issue of Cardiovascular Surgery.
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Robert D. Riether, MD, Director, Colon/Rectal Residency
Program; Khawaja Azimuddin, MD, former Colon/Rectal
Surgery resident; lndru T. Khubchandani, MD, Division of
Colon and Rectal Surgery; Lester Rosen, MD, Associate
Chief, Division of Colon and Rectal Surgery; and John J.
Stasik, MD, Chief, Division of Colon and Rectal Surgery, coauthored a paper-- "Transanal Endoscopic Microsurgery for
Excision of Rectal Lesions: Technique and Initial Results"-which was accepted for publication in a forthcoming issue of

Surgical Laparoscopy, Endoscopy &Percutaneous
Techniques.
Michael C. Sinclair, MD, Acting Chief, Division of CardiaThoracic Surgery; Martin LeBoutillier Ill, MD, Division of
Cardio-Thoracic Surgery; William Gee, MD, Division of
Vascular Surgery; Theodore Phillips, MD, Division of CardiaThoracic Surgery, and Raymond L. Singer, MD, Division of
Cardio-Thoracic Surgery, co-authored the paper, "Extraanatomic redo MIDCAB/OPCAB--an early experience," which
appeared in the June, 2000 issue of Heart Surgery Forum.

LVH Medical Staff Listing Available via Internttt
A listing of members of the LVH Medical Staff is
now available via the internet at the following
website: http://www.lvh.com. At the top of the
home page, click on "lvhhn.org," then, click on
"Physicians Directory." You may then select a
physician by last name or by specialty. This
information is updated on a monthly basis.

Who's New
The Who's New section of Medical Staff Progress Notes
contains an update of new appointments, address changes,
status changes, etc. Please remember to update your
directory and rolodexes with this information.

Medical Staff

Upcoming Seminars, Conferences and
Meetings
Medical Grand Rounds
Medical Grand Rounds will resume on Tuesday, September 5.
Medical Grand Rounds are held every Tuesday beginning at
noon in the Auditorium of Lehigh Valley Hospital, Cedar Crest
& 1-78, and via videoconference in the First Floor Conference
Room at Lehigh Valley Hospital-Muhlenberg, and in the Video
Teleconference Room (formerly the Medical Staff Lounge) at
17th & Chew.
Topics to be discussed in September will include:
~
~
~

~

September 5 - Selection of Appropriate Antibiotics for
Critically Ill Patients
September 12 - Remissive Therapies for Rheumatoid
Disease: Present- Future
September 19 - Up to Date: Access tot he Most Recent
Clinical Literature
September 26 - The Challenges of Developing Systems of
Coordinated Care for Older Adults

For more information, please contact Diane Biernacki in the
Department of Medicine at (610) 402-5200.

Address Changes
Frank J. Altomare, Jr., MD
Altomare &Associates
5930 Hamilton Blvd.
Allentown, PA 18106-9654
(610) 435-2001
Fax: (610) 435-6948
Bausch & Jones Eye Associates
~ Andrew N. Bausch, MD
~ David G. Jones, MD
Plaza West
1616 Allen Street
Allentown, PA 18102-2012
(610) 432-0201
Fax: (610) 434-1210
Frank DeFrank, MD
(No longer with Bethlehem Steel Family Health Center)
2246 High Road
Cresco, PA 18326-9708
Stephen P. Falatyn, MD
Orthopedic Surgical Group
701 Ostrum Street
Suite 602
Bethlehem, PA 18015-1153
(610) 807-9400
Fax: (610) 691-5533

Medical StaH Progress Notes

September, 2000 •:• Volume 12, Number 9

Page 10

(Continued from Page 9)

New Practice Name and Address

Fred Laufer, MD
4501 Crackersport Road
Allentown, PA 18104-9326
(61 0) 336-9000
Fax: (610) 336-9424

Wasserman, Redenbaugh, Margraf & Spikol, PC
New Practice Name - Valley Neurology Consultants, PC
~ John W. Margraf, MD
~ James E. Redenbaugh, MD
~ Lorraine J. Spikol, MD
~ Ronald E. Wasserman, MD
1210 S. Cedar Crest Blvd.
Suite 1000
Allentown, PA 18103-6208
(610) 434-0107
Fax: (610) 434-5337

Lehigh Valley Internists
~ David P. Carney, MD
~ Glenn S. Kratzer, MD
~ Judith A. McDonald, MD
~ Daniel T. Mulcahy, DO
~ John D. Nuschke, Jr., MD
~ Timothy E. Steckel, MD
798 Hausman Road
Suite 220
Allentown, PA 18104-9124
(610) 530-2290
Fax: (61 0) 530-2287
(Effective 8/28/00)
LVPG·Psychiatry
~ Joseph L. Antonowicz, MD
~ Yelena Yermak, MD
~ Kenneth J. Zemanek, MD
1251 S. Cedar Crest Blvd.
Suite 202A
Allentown, PA 18103-6214
(610) 402-5766
Fax: (610) 402-5763
(Effective 8/28/00)
Joseph T. Sembrot, MD
(Retired from VA Clinic)
1402 Cedarwood Road
Allentown, PA 18104-2112
(610) 395-4565
Howard A. Silverman, MD
798 Hausman Road
Suite 270
Allentown, PA 18104-9124
(610) 871-0100
Fax: (610) 871-0102
(Effective 9/1/00)

The 5th Edition of the Medical Staff Handbook
has been published and is now available in Medical
Staff Services and in the Medical Staff Lounge,
both on the first floor of Lehigh Valley Hospital,
Cedar Crest & I-78.

New Practice
Geraldo A. Saavedra, MD
(No longer with Sam Bub, MD, PC)
Medical Associates of Monroe County
239 E. Brown Street
Suite C
East Stroudsburg, PA 18301-3096
(570) 421-3872
Fax: (570) 421-0842

Practice Disassociation
Jenni Levy, MD
(No longer with LVPG-Medicine)
128 Fairhill Road
Hatfield, PA 19440

Pager Number Correction
In the new 5th Edition of the Medical Staff Handbook, the pager
number for D'nese M. Sokolowski, MD, was incorrect. Her
correct pager number is 610·778·7754.

Report from the Nominating Committee
The following name has been submitted by the
Nominating Committee for the position of
President-elect:
Alexander D. Rae-Grant, MD
An election will be held at the General Medical Staff
Meeting on September 11. Nominations will also be
accepted from the floor.
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Policy: Administrative
Subject: Withholding/Withdrawing
Treatment

Withholding/Withdrawing Treatment
I .. Policy
The Lehigh Valley Health Network has dedicated itself and its resources to the provision
of high quality, compassionate and ethical medical care to patients, their families and the
community at large. Lehigh Valley Health Network is dedicated to helping the people of
our service area achieve and maintain optimum health status. As a charitable, not-forprofit organization, we provide health services to our patients based on need, regardless
of ability to pay. As a part of that care, this hospital recognizes that
withholding/withdrawing medical treatment (including CPR) can be a part of a
patient/family's wishes, consistent with the patient's self-determination, the duties of the
health care professionals providing the care, and the mission of the hospital.
The Policy recognizes the relief of suffering, the stabilization of disease processes and the
curing of illness to be a spectrum of care which must be tailored to each patient's needs
and possibilities. It espouses the ancient professional adage, 11 TO cure sometimes, to
relieve often, to comfort always. 11
Purpose:

To provide the rationale and guidelines for withholding/withdrawing life-sustaining
medical treatment(s)
Presumptions:
A.

Patients may accept or refuse recommended medical care even when lifethreatening·conditions are present, whether or not they are tenninally ill. This is
the principle of autonomy or self-determination which has been upheld by the
courts and ethical scrutiny.

B.

Self-determination requires the patient with capacity (competent) to have
adequate information which he/she can understand and accept or reject without
coercion. Informed consent/refusal is a requirement of the legal and ethical
systems for the person who has capacity (is competent).

1
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C.

When a patient does not have the capacity to make decisions about medical
treatment, it is appropriate for a person who has either legal standing (guardian or
durable power of attorney) or a loving, caring familial relationship with the
patient to make medical decisions regarding his/her treatment. This person is
called a surrogate decision-mak-er and is a person (usually a family member)
who knows and has a caring relationship with the patient.

D.

Professional health care clinicians have duties toward the patient which are part of
the provider-patient relationship. The principle of beneficence or doing good for
the patient must be balanced with the patient's wishes and decisions. Informing
and convincing without coercion are part of that duty, trying to help the patient
make decisions which are consistent with his/her values.

E.

WITHHOLDING AND WITHDRAWING MEDICAL TREATMENTS are
equivalent acts from both a legal and ethical point of view. The conditions which
make withholding medical treatment legitimate also justify withdrawing similar
treatments. It is recognized that the two concepts in practice often feel different
and may elicit different emotional responses in carrying out the decisions.

F.

When comfort care is needed in withholding and withdrawing situations, the

principle of double effect is generally recognized and accepted. This principle
states that actions may have two effects and one of these effects is unintended.
These actions meant for comfort may hasten death but are not intended for that
end and have no acceptable alternatives. Pain and dyspnea control with adequate
analgesics, usually narcotics, become part of the treatment but may also hasten
death, the double effect.
G.

Food and/or fluid given by tube or intravenous means are considered medical
treatment and may be withheld/withdrawn under the same ethical pririciples as
other medical treatments such as CP~ mechanical ventilation, dialysis, etc.
Every effort should be made to continue nourishment by mouth whenever
feasible. (Refer to Attachment A)

H.

Withholding a specific treatment does not indicate that other care deemed
necessary for the patient will be diminished or not provided. The patient and
family should never be abandoned in fact or perception. Comfort measures and
compassionate caring must be continued and may need to be intensified when the
decision to withhold/withdraw has been made. Under no circumstances should
caring be withheld/withdrawn.

2
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I.

The hospital recognizes the difficulties of defining futility and futile medical
treatment but believes that there are situations where continuing previously
recommended aggressive therapy is medically useless and is counter to the
patient's best interestS (and perhaps his/her wishes) as well as the best interests of
the family; friends and society. A process for working through these situations is
provided in Attachment B.

J.

Thorough communications are required among the persons involved with the care
of the patient and with the patient and the family (if permitted by the patient).
The patient with decision-making capacity does not require a surrogate and should
make her/his own decisions about medical treatment and evaluation. If the
patient does not have the capacity to make autonomous decisions, information to
make informed consent/refusal needs to be provided to the appropriate surrogate
decision-maker. Patient, compassionate, understandable communication with the
patient or surrogate are required before and after decisions to pursue or
withhold/withdraw therapy. Meaningful communication ·between the patient and
the patient's family along with the multi disciplinary health care team and also
among the health care team should continue throughout the patient's illness and
hospitalization.

K.

Time-limited trials of therapy are possible because withholding and withdrawing
therapy are ethically and legally permissible. These trials permit time for
clarification of medical uncertainties by testing, observation and progression.
Because of continued reasonable uncertainty or changes in conditions, time. limited trials may be extended by mutual agreement among the health care team
and patient/surrogate but should not be used as a mechanism to avoid appropriate
but difficult decisions or to ignore the wishes of the patient/surrogate.

L.

This policy purposefully does not deal with health care costs and allocation of
scarce resources since these are issues which must be determined on a "macro" or
societal level and apply to all patients if they are to be equitable and fair. This
policy speaks to issues between individual patients and their surrogate(s) and the
health care team caring for that patient. This does not preclude the consideration
of medical futility as addressed in Section I and Attachment B.

M.

In Pennsylvania there is living will legislation which, if executed and signed by a
patient, may obligate the provider(s) to withhold/withdraw therapy which is lifesustaining if the patient is in an irreversible coma or has a terminal illness.
Conditions and prognoses which fall outside these parameters are not legally
binding, but, ethically, the living will must be i,nterpreted to attempt to understand
patients' wishes for a particular condition and prognosis applying to them at that
time. In Pennsylvania special requirements apply to pregnant women in the living
will legislation. (Pennsylvania Senate Bill #3).
3
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N.

A durable power of attorney for health care is a person designated in writing by
the patient (when mentally competent) to speak for the incapacitated patient in
medical decision making. The durable power does not become effective until the
patient is deemed incapacitated and cannot make decisions for her/himself. If the
patient should regain capacity the decision-mak.big authority reverts back to the
patient. If there is a durable power of attorney named, that person becomes the
designated surrogate decision-maker.

0. ·

CliniCal Circumstances:
1.

The patient with capacity (competent) should make decisions about his/her
own treatments. The patient should participate in appropriate discussions
with family and clinicians to assess information about diagnosis, prognosis
and benefits and burdens, allowing the patient to make an informed .·
decision. Persuasion, not coercion, is legitimate on the part of clinicians.
The family does not have the ethical or legal right to make decisions for a
competent patient without that patient's consent or formal transfer of
decision-making authority.

2.

Patients who lack capacity for decision-making can be represented by a
legitimate surrogate decision-maker who tries to use substituted
judgment to extend the patient's wishes. The surrogate should interpret
the information and make decisions as they believe the patient would if
he/she could make the decision autonomously. If the surrogate does not
have enough.inform.ation about the patient's previous wishes or thoughts
about death and dying, suffering, pain, quality of life, etc., to make a
substituted judgment decision, the principle of best interest can be used.
This weighs the benefits and burdens of the active pursuit of medical care
and assesses whether or not the benefits outweigh the burdens. If so,
therapy should be continued, if not, therapy can be withheld/withdrawn.

3.

Persons who never had capacity to be autonomous (children, never
competent adults, etc.), present different problems in decision making
since autonomy has never been achieved. Therefore decisions must be
made using the principles of beneficence and non-maleficence. In these
cases surrogates must be designated for the patients and these surrogates
should make decisions in the best interest of the patients. It may be
necessary to ask the courts to appoint a guardian who will act as a
surrogate in some of these cases.

4
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4.

A previously autonomous person who is now incapacitated and who has
no known relatives or family or other legitimate surrogate, presents a
difficult set of problems for the health care providers. In most cases the
health care team in consultation with the Ethics Committee and Legal
Services can reach a consensus about an appropriate course of action. If
the issue is controversial with divergent opinions, a judge may be asked to
intervene and appoint a guardian.

ll. Scope
Adult patients with capacity to make health care decisions or appropriate surrogate(s).

Ill. Definitions
Types of Treatments:
Examples of life-sustaining medical treatment include, but are not limited to, the
·
following:
A.
Cardiopulmonary resuscitation
B.
Mechanical Ventilation with intubation
C.
No Non-Invasive ventilation for any reason (Bi-PAP)
D.
Dialysis
E.
Artificial hydration and nutrition
F.
Antibiotic therapy and other life-sustaining medications
G.
Achninistration of blood and blood products
H.
Surgery

IV. Procedure
A.

Decisions to withhold or withdraw medical therapy should be a result of continual
interchange of information and ideas between the health care team and the
patient/surrogate.

B.

Once the decision has been made to limit medical therapy, an order must
be written by the attending physician defining the limits.

C.

A progress note should reflect the thinking and process used to arrive at the
decision to limit therapy.

5
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D;

When the decision is made to withhold therapy, the Withholding of Therapy
Order Sheet must be completed as well as an order to this effect on the blue
order sheet.

E.

The Withholding·OfTherapy Order Sheet will be placed inside the front cover of
the chart, (the first document in the chart).

F.

When a Withholding Order is stopped, "VOID" will be written across the care
.order check Sheet and it will be moved to the order sheet section of the chart. The
order must be written on the usual order sheet as well. If the Withholding Order is
later re-instated, a new form must be completed.

G.

Whenever a patient with a Withholding·Order leaves a patient care unit, the
receiving department should be contacted by phone to alert them about the
patient's withholding status, e.g. going to x-ray for chest file, etc., or patient for
therapy.

H.

It is the responsibility ofthe receiving department to clarify the order, chart or
phone message if not clearly understood by them.

I.

Canceling a Withholding of Therapy Order requires discussion and
documentation similar to that required to write a Withholding order. The
communication of the change must be transmitted to all who need to !mow.

J.

If a patient with a Withholding of Therapy Order has a procedure (test, therapy,
etc.) which has some risk of causing a cardiac and/or respiratory arrest,
clarification by the patient or appropriate surrogate regarding resuscitation is
required. This should be obtained by the attending physician and affirmed by the
physician performing the procedure as well as the anesthesiologist. This should
be documented in the record.

K.

If conflict arises concerning the decision a team/family conference should be held
to attempt to clarify the issues and develop consensus.

L.

If the team/family conference along with input from other sources does not
resolve the conflict, an Ethics Consultation should be requested. (Refer to, Ethics
Consultation Process Policy)

6
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V. Attachments
Attachment A - Artificial Nutrition and Hydration
Attachment B - Futile* Care
Attachment C - Withholding/Withdrawing Treatment Order Sheet

VI. Distribution
Administrative Policy Manual

VIT. Approval

Signature

President & CEO
Title

Date

Signature

President of Medical Staff
Title

Date

Vlll. Policy Responsibility
In Coordination With:

President and Chief Executive Officer

Ethics Committee
Medical Staff
Legal Affairs

IX. References
Withholding/Withdrawing Life-Sustaining Therapy, Official Statement of the American
Thoracic Society, American Review of Respiratory Disease September 1991; Volume
144, No. 3:726-731.
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Consensus Report on the Ethics of Foregoing Life-Sustaining Treatments in the Critical
Ill, Critical Care Medicine December, 1990; Volume 18:1435-1439.
Ethical and Moral Guidelines for the Initiation, Continuation and Withdrawal of Intensive
Care, ACCP/SCCM Consensus Panel, Chest April1990; Volume 97:949-958.
Schneiderman, Lawrence J. and Spragg, Roger G., Ethical Decisions in Discontinuing
Mechanical Ventilation, New England journal of Medicine Aprill4, 1988;984-988.
Luce, John M. and Faffin, Thomas A., Withholding and Withdrawal of Life Support from
Critically Ill Patients /September 1988; Volume 94:(3) 621-626.

X. Disclaimer Statement
This policy and the implementing procedures are intended to provide a description of
recommended courses of action to comply with statutory or regulatory requirements
and/or operational standards. It is recOgnized that there may be specific circumstances,
not contemplated by laws or regulatory requirements, that make compliance
inappropriate. For advice in these circumstances, consult with the Department of Risk
Management/Legal Services.

XI. Revision Dates
Origination: August 1995
Review/Revised: March 2000
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ATTACHMENT A

ARTXFICIAL NUTRITION AND

~RATION

1.

Ethically and legally, artificial nutrition and hydration is
no different than other forms of life-sustaining medical
treatment. In appropriate cases, discontinuing certain
medical treatments is accepted despite the fact that death
is as certain as with withholding medical nutrition and
hydration. Withholding dialysis in a patient without kidney
function is an example.

2.

In many instances, the burden of administering artificial
nutrition and hydration outweighs potential benefits. Such
burdens include: risk of infection such as pneumonia and
sinusitis secondary to nasogastric tubes, discomfort
secondary to nasogastric tube, and risks of hemorrhage,
infection, fluid overload, and thrombosis associated with
central venous parenteral alimentation.

3.

Potentially beneficial effects of dehydration in the
terminal patient include decrease in G.I. fluid resulting in
less vomiting, reduction in pulmonary secretions with less
coughing and drowning sensation, and reduction in edema
around tumors leading to decreased pain.

4.

Studies have addressed the comfort of terminally ill
patients from whom artificial nutrition and hydration was
withheld.
Physiologic adaptation to fasting leads to lipolysis and
increased ketone production which decreases the feeling of
hunger.
Most patients studied never expe~ienced any hunger. When
present, symptoms of hunger, thirst and dry mouth were
alleviated with small amounts of food and fluid given orally
or by the application of ice chips and lubrication of the
lips.
Although it has been felt that the major distressing symptom
of dehydration is dry mouth, Hospice experts report that
dying patients who are dehydrated are rarely thirsty.

5.

The provision of nutrition and hydration has been equated
with care and compassion. It is, nevertheless, possible to
provide a high level of compassion and dignity to the dying
patient without artificial nutrition.
References:
l..

McCann, et al. Comfort Care of Terminally I l l Patients - The Appropriate
Use of Nutrition and Hydration. JAMA,l.994:276(l.6) ;l.263-l.266.

2.

Andrews, ,MR and Levr~, AM. Dehydration in the Terminal Patient:
Perception of Hospice Nurses. The American Journal of Hospice Care.

January/February l.989;3l.-34.
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ATTACHMENT B
FUTILE* CARE

Purpose:

To provide guidelines when the attending physician
believes that further care (other than comfort care) is
futile, but the patient or the patient's family insist
on continuing the effort. This statement does not apply
to rationing medical care and should not be used for
this purpose.

1

The attending physician should take enough time to carefully
explain to the aware patient and to the family the nature of
the, ailment, the options and the prognosis. The physician
should explain that abandoning the. treatment does not mean
abandoning the patient in terms of comfort, dignity and
psychological support.

2

The attending physician should provide the names of
appropriate consultants to provide an independent opinion
concerning the futility of the situation.

3

The assistance of the nurses, chaplain, patient
representative and social services should be offered to the
patient's family. A joint conference with the doctor is
desirable.

4

An Ethics Consultation may be called to consider the matter
and offer advice and counsel to the physician, family and
healthcare team. {Refer to AD#l600.06, Ethics Consultation
Process)

5

Adequate time should be given for the patient and family to
consider this information.

6

If all of these steps are taken and the family remains
unconvinced, neither the doctor nor the hospital are
required to provide care that is not medically indicated,
and the family may seek a substitute physician (if one can
be found) and another hospital (if available). The Lehigh
Valley Hospital will assist the family in their efforts to
find those substitutes.

7

If the patient can no longer benefit from an acute hospital
stay and the patient or family insists on staying, the
mechanism for personal payment can be invoked.
FUTILE* CARE - Any clinical circumstance in which the doctor and
his/her consultants, consistent with the available medical
literature, conclude that further treatment (except comfort care)
cannot, within reasonable possibility, cure, improve or restore a
quality of life that would be satisfactory to the patient.
References: Rivin, AU. Are Futile-Care Policies The AnSWer? Hospitals and
Health Networks,l994:February 20.

IIIII

LEHIGH VALLEY HOSPITAL
ALLENTOWN, PA
LEHIGH VALLEY HOSPITAL· MUHLENBERG
BETHLEHEM, PA
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WITHHOLDING OF THERAPY

ORDER SHEET
(Also write •see 'Mthho/ding Order Sheer on the regular order sheet).

WITHHOLDING OF THERAPY ORDER
The patient and/or surrogate request the withholding of medical therapy as indicated below: (Currently active orders will continue until
altered by further orders.)

~~n

,-

0
0
0
0
0
0
0
0
0
0
0
0
0
0

No CPR-cardiopulmonary resuscitation, code blue, ACLS Protocol
No Electrical defibrillation
No Mechanical ventilation with intubation for any reason
No Non-Invasive mechanical ventilation for any reason (bi-pap)
No Vasopressorslionotropic agents
No Antiarrhythmics
No Dialysis ·
No Hyperalimentation
No Tube feedings
No Blood or blood products
No Antibiotics
No Electrolytes or acid/base corrective measures
No Treatment for low urine output
No Transfer to ICU or monitored bed

The above list is not meant to be all-inclusive. If the patient's/surrogate's wishes cannot be expressed through this list, clarify and
explain those wishes below.

I have discussed this with the patient/patient surrogate - - - - - - - - - - - - - - - - - - - - - , - - - - who understands the order.
NAME
PHYSICIAN'S SIGNATURE

PRINTED NAME

STATUS CHANGE

D

DISCONTINUE THE ABOVE ORDER(S) IMMEDIATELY.
(See next order sheet for specific orders)

PHYSICIAN'S SIGNATURE

PRINTED NAME

{ALSO, WRITE ORDER TO DISCONTINUE WITHHOLDING STATUS ON REGULAR ORDER SHEET)

MRD-36 Rev. 6/00
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LEHIGH VALLEY HOSPITAL
WITHHOLDING OF THERAPY ORDER SHEET

1.

The Withholding Order Sheet will be placed inside the front cover of the chart, (the first
document in the chart).

2.

When a no CPR order is stopped, 'VOID" will be written across the order check sheet and it
will be moved to the order sheet section of the chart. The order must be written on the usual
order sheet, as well. If the no CPR is later reinstated, a new form must be completed.

3.

Whenever a patient with a no CPR order leaves a patient care unit, the receiving department .
should be contacted. by phone to alert them about the patient's resuscitation status, e.g.,
going to X-ray for chest film, etc., or patient for therapy. This should be done by the primary
nurse or his/her designee.

4. · It is the responsibility of the receiving department to clarify the order if the chart or phone
message is not clearly understood by them.
5.

Cancelling a no CPR order requires discussion and documentation similar to that required to
write a no CPR order. The communication of the change must be tran~mitted to all who
need to know.

6.

If a patient with an active no CPR order has a procedure (test, therapy, etc.) which has some
risk of causing a cardiac and/or respiratory arrest, clarification by the patient or appropriate
s~rrogate regarding resuscitation is required. This should be obtained by the attending
physician and affirmed by the physician performing the procedure.

MRD-36

Rev. 6/00
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HOSPITAL

THERAPEUTICS AT A GLANCE
The following actions were taken at the July/August 2000 Therapeutics Committee Meeting- James Sianis, Pharm.D., Christopher Moore,
PharmD., Joseph Ottinger, R.Ph., MS, MBA

ADR Reporting
Suspected ADR reports for the second quarter of
2000 demonstrated a similar quantity of notations
and 'severity' to those of the previous quarter.
Anticoagulation therapies continue to comprise the
largest measure of reports considered "Severe" .
Comparative incident/volume activity levels (e.g.,
reports per 10,000 doses administered and reports
per 1,000 adjusted admissions) were almost
identical to the previous quarters data. One death
was recorded in the 61 reports. Drug therapy was
not considered to be a primary contributing factor.
An additional report of bleeding associated with
use of enoxaparin in a patient with a calculated
estimated creatinine clearance of < 30 ml/min was
noted. This drug is renally excreted. Physicians
are reminded that use of enoxaparin in patients with
an estimated creatinine clearance of less than 30
ml/min. is not widely studied. These patients were
excluded from all the major published studies to
date. Therefore, dosing alterations are not well
described. In addition, patients would require
laboratory monitoring via use of ant-factor Xa
heparin activity levels. Pharmacy "notes" restating
this information are placed on appropriate patient
charts identified through a daily monitoring process.
All health-care personnel are encouraged to report
suspected adverse drug reactions. Copies of the
Suspected Adverse Drug Reaction Documentation
Form are available in all patient care areas.
Complete as many portions of the form as you can
or at least notify the Pharmacy staff of your
observations. A pharmacist will review the case
and complete/initiate the form as necessary. ALL

REPORTS are confidential and they are
summarized and presented to the Therapeutics
committee. Cause-effect analysis and trending
considerations are reviewed in this process. Patient
allergy data are updated in accordance with the level
of suspicion based on the Naranjo scale and
patient's may receive "ID" cards describing the
nature of the reactions and the presumed associated
cause. This information card can be carried by the
patient and presented in future health-care
interventions requiring drug treatments. ·
Following are the particulars for this quarter
Second quarter
First auarter
Reports per 10,000 doses 0.63
0.62
Reports per 1,000 admissions 5.53
5.54
Second Quarter Data
Table 1: Adverse Reactions By Reporter
%Reports
67.2
27.9

Reporter
#Reports
341
Pharmacist
17
Nurse
X-Ray Technician
3
o_
Physician
61
TOTAL

4.9

_o_
100

Table 2: Adverse Reactions By Drug Category
Drug Category
Antibiotics
Contrast Dyes
Psych/Neurologic Agents
Narcotic Analgesics
Anticoagulants
Dopamine
Cardiac
Oncology
Other
TOTAL

#Reports
12
9
7

3
16
0

3
5

%Reports
19.7
14.8
11.5

4.9
26.2
0

4.9

___§

8.2
9.8

61

100
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Table 3:

Probabilit~of Drug-Related Reactions

Probability
Doubtful
Possible
Probable
Highly Probable
TOTAL

#Reports
0

20
38
_2
61

% Reports
0
32.8
62.3
4.9
100

Table 4: Adverse Reaction Severity
Classification
Mild
Moderate
Severe
TOTAL

# Reports
24
23
_H
61

%Reports
39.3
37.7
23.0
100

Most Common Agent
Contrast dye- 8
heparin w/others- 6
Abciximab (WI HEP)- 3

Drug Formulary Issues
The Therapeutics Committee at its August meeting
approved the addition of the Class III
antiarrhythmic, dofetilide (Tikosyn). Dofetilide is
indicated for the conversion of atrial fibrillation
and atrial flutter to normal sinus rhythm. It has
not been shown to be effective in patients with
paroxysmal atrial fibrillation. Dofetilide is also
indicated for the maintenance of normal sinus
rhythm in patients with atrial fibrillation and atrial
flutter of greater than 1 week duration who have
been converted to normal sinus rhythm. Because
dofetilide is associated with life-threatening
ventricular arrhythmias, its use should be reserved
for patients in whom atrial fibrillation or atrial
flutter is highly symptomatic.
Therapy with dofetilide must be initiated or reinitiated only in patients placed for a minimum of
3 days in a facility that can provide calculations of
creatinine clearance, continuous
electrocardiographic monitoring, and cardiac
resuscitation in order to minimize the risk of
induced ventricular arrhythmias. In addition, only
those physicians certified to prescribe dofetilide
may initiate (re-initiate) therapy.

Initiation of therapy will require use of a
preprinted order form that provides all the
mandated monitoring and prescribing information
necessary to facilitate therapy. Patient education
materials will also be given to the patient that
highlight the need for screening for drug-drug
interactions prior to the initiation of 'other'
therapies .. Once the patient leaves the Hospital,
drug must be obtained from Stadtlander's
Pharmacy (the only licensed Pharmacy supplier)
via mail order. The patient does receive a 7 day
supply of medicine upon discharge from the
hospital that provides a 'bridge' until the
Stadtlander's materials arrive.
Patients re-admitted to the hospital may have
therapy continued by the attending service, unless
therapy is discontinued for longer than 24 hours
(Must be reinitiated via protocol). These patients
will have a Pharmacy information sheet placed on
the chart elaborating drug interactions and other
particulars. (See attached)
Also reviewed and approved to the formulary was
the short-acting, non-depolarizing neuromuscular
blocker rapacuronium (Raplon). Rapacuronium is a
rapid onset neuromuscular blocker with a short
duration of action. It may be possible to use
rapacuronium as a replacement for succinylcholine
and other neuromuscular blockers, in selected
situations. (See contraindications)
An additional niche for rapacuronium use has been
identified in 'short' procedure cases, where it would
be utilized to replace the 'longer half-life' agents
currently utilized facilitating a faster recovery. The
Anesthesia department
has developed usage
guidelines for this agent, which are described below.
Cases where an agent with the duration of
action less than 30 minutes are needed.
Cases in which succinylcholine is
contraindicated and rocuronium is
inappropriate.
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Pediatricicas~s greater than 1 month of age
where rocuronium is contraindicated.
When cases exceed a 30 minute time limit,
use of a second muscle relaxant is
indicated.
Current Contraindications for the use of
Succinylcholine
Hypersensitivity to succinylcholine.
Patients with a personal or family history of
malignant hyperthermia or a history of skeletal
muscle myopathy.
Patients in the acute phase of injury with major
burns, multiple trauma, extensive denervation of
skeletal muscle or upper motor neuron injury.
Acute narrow angle glaucoma.
Penetrating eye injury.

indicated for the management of the pain
associated with osteoarthritis as well as acute pain.
The advantage of agents such as rofecoxib is the
ability to take advantage of the properties of an
NSAID, without the undesirable side effects of
traditional NSAIDS. The committee also voted to
allow the pharmacy to automatically substitute
rofecoxib for celecoxib(Celebrex) when ordered by
the residents and medical staff. The following
scheme will be used for this substitution:
Celecoxib up to 200 mg per day- Rofecoxib 12.5
mg PO qd
Celecoxib
POqd

Also has 'black box' warning for risk of cardiac
arrest from hyperkalemic rhambdomyolysis in
otherwise healthy pediatric patients.

Heparin Order sheet
A revised intravenous heparin order sheet has been
developed to facilitate use of this important agent.
The order sheet will contain the more widely used
dosing schemes, but physicians will be able to
describe individually tailored regimens, if
necessary. The order format was approved, but
the form will be 'held', as the laboratory will
shortly be converting to a more sensitive reagent
to measure aPTT. Notification of the new
therapeutic range will be forthcoming in a future
edition of this newsletter.

Vioxx (Rofecoxib) Approved for
Formulary
After much anticipation, Therapeutics committee
voted to add rofecoxib (Vioxx) to the LVH
formulary. This agent selectively inhibits the cox2 enzyme and prevents the synthesis of
inflammatory prostaglandins. Rofecoxib is

pt\800hi. wpd

> 200-400 mg/ day

- Rofecoxib 25 mg
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Dofetilide Infor\naqon Sheet
Dear Doctor,
This patient has been prescribed dofetilide (Tikosyn). Please, be aware that these patients should be closely
monitored for changes in renal function, prolonged QT interval and electrolyte (potassium) disturbances. In
addition, this agent is contraindicated with certain drugs and should be administered with caution when given
with other agents that prolong the QT interval. Below is a list of agents that have been identified as
potentially problematic.
Additionally, patients NOT receiving therapy for longer than 24 hours should be re-titrated on dofetilide
using the FDA mandated dosing schedule. This will require that a Physician certified via the FDA mandated
program to initiate (reinitiate) therapy be contacted. Pharmacy can provide a list of those individuals whose
credentials are on file.
Tikosyn (dofetilide) can NEVER be co-administered with verapamil (lsoptin; Calan), ketoconazole (Nizoral),
cimetidine (Tagamet), trimethoprim (Trimpex, Bactrim, Septra), prochlorperazine (Compazine), or
megesterol (Megace).
In addition, the following list of drugs may prolong the QT interval and precipitate irregular heart beats.
They are best avoided if you are receiving Tikosyn (dofetilide).
GENERIC NAME
Bepridil
Ciprofloxacin
Cisapride
Diphenhydramine
Disopyramide Epinephrine
Erythromycin
Fluconazole
Haloperidol
Indapamide
Itraconazole
Levofloxacin
Pentamidine
Phenothiazine derivative
Pimozide
Procainamide
Quinidine
Risperidone
Sotalol
Tricyclic antidepressants

POTASSIUM LOSS
In addition to these drugs, try to avoid low blood potassium and probably low magnesium as well. Low
blood potassium levels can prolong the QT interval and precipitate the irregular heart beats of the Long QT
Syndrome.
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September, 2000

News from the Library

Computer-Based Training CCBD:

OVID Training.
The Library has completely converted to OVID's on-line
MEDLINE system. This Web-based system is updated daily by
Ovid. Call Barbara Jobst in the Health Sciences Library at 610402-8408 to schedule a one-on-one training session.

NEW TELEPHONE/FAX NUMBERS FOR
LEIDGH VALLEY HOSPITALMUHLENBERG LmRARY.
Please use the following telephone nwnber when requesting
information from the LVII-Muhlenberg Library: 610-401-8410.
For faxing requests to the LVII-Muhlenberg campus Library, the
fax nwnber is 610-402-8409.
The new nwnbers enable the Library staff to consolidate services
in order to better serve our customers and control costs.

Computer Based Training (CBT) programs are available for
LVHHN staff. Topics covered by the CBT programs include:
Access 2.0
Power-Point 4.0
Windows NT 4
Word 97
Excel 97
Access 97
PowerPoint 97
Lotus 1-2-3 Millenniwn
WordPerfect 8
E-mail GUI
PHAMIS LastWord Inquiry Only commands
CBT programs replace the instructor-led classes previously held
at Lehigh Valley Hospital. A proctor will be in the room with
the learner while he/she takes the CBT, but the learner will
control the pace and objectives of the learning.
Computer Based Training takes place in Suite 401 of the John
& Dorothy Morgan Cancer Center (the computer training
room) and in the Muhlenberg Hoapital Center computer
trainln& room (off the front lobby). The schedule of upcoming
dates is as follows:
CBT sessions for JDMCC, suite 40 I are as follows:

IN THE LITERATURE.

September 12, Sam - Noon

This is a reminder about the recent debut of our new, :free tableof-contents service, "IN THE LITERATURE." You need not
visit the library to keep abreast of the latest medical
information. From your PC, you can peruse the table of contents
of such widely-read journals as"JAMA," "New England Journal

Sessiogs at MUC, I.S. Training room are as follows:

ofMedicine," "Lancet," "Obstetrics and Gynecology,"
"Journal of Trauma," "Archives ofSurgery," "American
Journal ofMedicine," "Critical Care Medicine," "American
Journal ofPublic Health," "Pediatrics," "Annals ofInternal
Medicine," "American Heart Journal, and "Nature," etc. This
table-of-contents service allows you to request photocopies of

articles published in these journals. Information about this
service, a complete list of journal titles, and instructions
explaining how to request an article can be found by visiting the
LVHHN Intranet Click on the mow in the "•Resources•" box
to display the drop-down menu. Select "Clinical." On the next
screen, captioned "Clinical Links & Resources," click on "Table
of Contents Service." If you need assistance in obtaining
information about "IN THE LITERATURE," call61 0-4022263 or 610-402-841 0

1

September 26, Sam - Noon
Twelve slots are available for each session.
To register, please contact Suzanne Rice via e-mail or at 484SS4-2560 with the following:
date of session
second date choice
department
phone nwnber
You will receive an e-mail confirming your choice within two
business days. If you have any questions, please contact Craig
Koller at 610-402-1427 or through e-mail.
Any questions, concern& or comments on articles from CEDS, please
contact Bonnie Schoeneberger 610-402-1210

Sunday

Monday

Tuesday

Wednesday

Thursday

Friday

1

September 2000
5

3

8

1.-n Pediatric GR- CC-Aud
12 noon Medical GR-CC-Aud

10

11

12
7.rn Surgical GR-CC-Aud

a.n Pediatric GR-CC-Aud

18
12noon Colon/Rectal
TB-JDMCC-CR1

24

125

13

14

112noon Pulmo TB-JDMCC 112noon Endo TBCR1

19
I

20

JDMCC-CR1

126

127

21
12noon Combined TB-

7.rn Surgical GR-CC-Aud
B.rn Pediatric GR-CC-Aud
12 noon Medical GR-CC-Aud

7.rn Surgical GR-CC-Aud
a.n Pediatric GR-CC-Aud
12noon Urology TB-JDMCCCR1
12 noon Medical GR-CC-Aud

9

7.rn OBGYN GR-CC-CL1
12noon Breast TB-JDMCCCR1

12 noon Medical GR-CC-Aud

17

2

7.rn GYN Tumor Board-CCCL1
12noon Breast TB-JDMCCCR1

7

6

Saturday

JDMCC-CR1

128

12noon Combined TBJDMCC-CR1

15

16

22

23

'29

130

7.rn OBGYN GR-CC-CL1
12noon Breast TB-JDMCCCR1

7.rn OBGYN GR-CC-CL1
12noon Breast TB-JDMCCCR1

7.rn OBGYN GR-CC-CL1
12noon Breast TB-JDMCCCR1
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